Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 58,874,321
Number of holders: 109
Total 13F shares, excl. options: 35,159,995
Shares change: +3,173,069
Total reported value, excl. options: $571,479,438
Value change: +$57,348,441
Put/Call ratio: 16%
Number of buys: 60
Number of sells: -42
Price: $16.25

Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2014

139 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2014.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35,159,995 shares of 58,874,321 outstanding shares and own 60% of the company stock.
Largest 10 shareholders include FMR LLC (4,515,096 shares), BAKER BROS. ADVISORS LP (4,445,696 shares), Palo Alto Investors, LLC (3,215,424 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,751,881 shares), State Street Corp (1,554,430 shares), Invesco Ltd. (1,484,145 shares), PAULSON & CO INC (1,392,500 shares), BlackRock Fund Advisors (1,336,039 shares), Consonance Capital Management LP (1,226,772 shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (1,153,942 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.